Peapack-Gladstone Financial Corp’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.8M Sell
98,944
-496
-0.5% -$177K 0.45% 59
2025
Q4
$32.5M Sell
99,440
-8,887
-8% -$2.82M 0.41% 67
2025
Q3
$30.6M Sell
108,327
-2,049
-2% -$594K 0.4% 73
2025
Q2
$30.8M Sell
110,376
-4,108
-4% -$1.16M 0.44% 68
2025
Q1
$35.7M Buy
114,484
+716
+0.6% +$211K 0.53% 54
2024
Q4
$29.7M Sell
113,768
-2,078
-2% -$617K 0.43% 68
2024
Q3
$37.3M Sell
115,846
-27
-0% -$8.83K 0.54% 55
2024
Q2
$36.2M Buy
115,873
+2,240
+2% +$658K 0.56% 44
2024
Q1
$32.3M Buy
113,633
+4,112
+4% +$1.2M 0.51% 52
2023
Q4
$31.5M Buy
109,521
+313
+0.3% +$85.3K 0.53% 50
2023
Q3
$29.4M Buy
109,208
+767
+0.7% +$191K 0.54% 50
2023
Q2
$24.1M Buy
108,441
+15,625
+17% +$3.63M 0.43% 67
2023
Q1
$22.8M Sell
92,816
-5,616
-6% -$1.38M 0.43% 67
2022
Q4
$25.9M Buy
98,432
+3,452
+4% +$925K 0.51% 60
2022
Q3
$21.4M Buy
94,980
+8,932
+10% +$2.17M 0.44% 66
2022
Q2
$20.9M Buy
86,048
+7,689
+10% +$1.88M 0.48% 63
2022
Q1
$18.9M Buy
78,359
+2,017
+3% +$463K 0.37% 74
2021
Q4
$17.2M Buy
76,342
+1,784
+2% +$377K 0.32% 83
2021
Q3
$15.9M Buy
74,558
+808
+1% +$186K 0.33% 81
2021
Q2
$18M Sell
73,750
-34
-0% -$8.36K 0.43% 66
2021
Q1
$18.4M Buy
73,784
+5,085
+7% +$1.21M 0.47% 61
2020
Q4
$15.8M Buy
68,699
+1,492
+2% +$344K 0.47% 63
2020
Q3
$17.1M Buy
67,207
+2,865
+4% +$710K 0.62% 48
2020
Q2
$15.2M Buy
64,342
+1,438
+2% +$328K 0.6% 47
2020
Q1
$12.8M Sell
62,904
-3,460
-5% -$756K 0.6% 49
2019
Q4
$16M Sell
66,364
-1,262
-2% -$278K 0.64% 51
2019
Q3
$13.1M Sell
67,626
-289
-0.4% -$55.5K 0.56% 56
2019
Q2
$12.5M Sell
67,915
-1,038
-2% -$186K 0.54% 58
2019
Q1
$13.1M Sell
68,953
-888
-1% -$170K 0.59% 55
2018
Q4
$13.6M Buy
69,841
+109
+0.2% +$21.3K 0.7% 48
2018
Q3
$14.5M Buy
69,732
+1,085
+2% +$214K 0.71% 49
2018
Q2
$12.7M Sell
68,647
-255
-0.4% -$45.1K 0.66% 53
2018
Q1
$11.7M Buy
68,902
+245
+0.4% +$45K 0.64% 57
2017
Q4
$11.9M Buy
68,657
+267
+0.4% +$47.3K 0.64% 61
2017
Q3
$12.8M Sell
68,390
-340
-0.5% -$60.2K 0.73% 51
2017
Q2
$11.8M Sell
68,730
-599
-0.9% -$97.4K 0.71% 53
2017
Q1
$11.4M Buy
69,329
+1,467
+2% +$244K 0.7% 53
2016
Q4
$9.92M Buy
67,862
+914
+1% +$138K 0.64% 56
2016
Q3
$11.2M Buy
66,948
+694
+1% +$117K 0.75% 46
2016
Q2
$10.1M Buy
66,254
+3,524
+6% +$548K 0.7% 52
2016
Q1
$9.41M Buy
62,730
+5,239
+9% +$778K 0.66% 55
2015
Q4
$9.33M Buy
57,491
+967
+2% +$152K 0.65% 50
2015
Q3
$7.82M Buy
56,524
+1,623
+3% +$256K 0.59% 54
2015
Q2
$8.43M Buy
54,901
+1,010
+2% +$162K 0.59% 56
2015
Q1
$8.61M Buy
53,891
+639
+1% +$101K 0.6% 53
2014
Q4
$8.48M Buy
53,252
+1,089
+2% +$170K 0.6% 55
2014
Q3
$7.33M Buy
52,163
+8,265
+19% +$1.08M 0.55% 56
2014
Q2
$5.2M Buy
43,898
+6,484
+17% +$751K 0.39% 77
2014
Q1
$4.61M Buy
37,414
+915
+3% +$111K 0.36% 80
2013
Q4
$4.16M Buy
36,499
+3,978
+12% +$453K 0.34% 86
2013
Q3
$3.64M Buy
32,521
+8,850
+37% +$960K 0.32% 87
2013
Q2
$2.34M Buy
+23,671
New +$2.46M 0.21% 102

Other funds holding AMGN

Peapack-Gladstone Financial Corp's AMGN Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp reduced its Amgen (AMGN) stake by 0.5% in Q1 2026, selling an estimated $177K and leaving 98,944 shares worth $34.8M. The position accounts for 0.45% of the portfolio, ranked #59.

Peapack-Gladstone Financial Corp first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.3M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Peapack-Gladstone Financial Corp held 98,944 shares of Amgen worth $34.8M as of Q1 2026.
  • Peapack-Gladstone Financial Corp sold 496 Amgen shares in Q1 2026, an estimated $177K.
  • Amgen made up 0.45% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #59 holding.
  • Peapack-Gladstone Financial Corp first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Peapack-Gladstone Financial Corp's Amgen position peaked at $37.3M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.